Edge Rewrite
// HTMLRewriter · presentation

This page was redesigned at the edge.

Cloudflare fetched the original article and streamed it through HTMLRewriter to apply an entirely new visual system without rebuilding the source page.

// request.cf · coarse context

A page that knows where it met you.

Only coarse request metadata is shown. This demo does not display or persist visitor IP addresses.

Country
US
Cloudflare location
CMH
Connection
HTTP/2
Language
Not provided

Ray ID: a256147f8dc899fe

Jump to content

Talk:DAM-57

Page contents not supported in other languages.
Add topic
From Wikipedia, the free encyclopedia
Latest comment: 9 months ago by Jeffrey34555 in topic Requested move 19 October 2025

Requested move

[edit]
The following discussion is an archived discussion of a requested move. Please do not modify it. Subsequent comments should be made in a new section on the talk page. Editors desiring to contest the closing decision should consider a move review. No further edits should be made to this section.

The result of the move request was: moved per request. Uncontested for more than a week. Favonian (talk) 14:11, 6 October 2013 (UTC)Reply


DAM-57Dimethyllysergamide – Dimethyllysergamide is a more appropriate name for the article, & DAM-57 could redirect to it. DAM-57 is simply an acronym for the name Dimethyllysergamide, but Dimethyllysergamide is the actual name of the compound. Likewise, the article for LSD is not titled LSD, but rather Lysergic acid diethylamide (and LSD redirects to it). Furthermore, the only reason I was unable to move the page myself is because the page Dimethyllysergamide already existed...however, I'm the one who created it (by mistake; I copy-&-paste moved it, & then was informed by another user about the proper way to move a page, via the 'move' function, whilst preserving page history). Otherwise, I'd just move it myself. Psychonaut25 - 13375p34k / C0n7r1b5 18:43, 27 September 2013 (UTC)Reply

The above discussion is preserved as an archive of a requested move. Please do not modify it. Subsequent comments should be made in a new section on this talk page or in a move review. No further edits should be made to this section.

Requested move 19 October 2025

[edit]
The following is a closed discussion of a requested move. Please do not modify it. Subsequent comments should be made in a new section on the talk page. Editors desiring to contest the closing decision should consider a move review after discussing it on the closer's talk page. No further edits should be made to this discussion.

The result of the move request was: moved. (closed by non-admin page mover) Jeffrey34555 (talk) 21:14, 26 October 2025 (UTC)Reply


DimethyllysergamideDAM-57 – "DAM-57" is the Sandoz developmental code name of the drug and is much more commonly used in the literature than the chemical name "dimethyllysergamide" (which is one of multiple different possible chemical names, others being "N,N-dimethyllysergamide" and "lysergic acid dimethylamide"). Per Google Scholar search results, "DAM-57" (with some disambig terms) gets 39 results (), while "dimethyllysergamide" gets 8 results (). In relation to the preceding, "DAM-57" is the common/trivial name of the compound. Moreover, typically on Wikipedia in drug-related articles, we use the developmental code names rather than chemical names as the titles of articles for investigational drugs. Finally, many other analogues or related drugs in the same series use the Sandoz developmental code name for the article title rather than a chemical name, including LAE-32, ALA-10, MLA-74, LME-54, ALD-52, LBB-66, LPD-824, MPD-75, and LSM-775. The articles in this area should follow the same naming scheme for consistency. Some exceptions include LSD (LSD-25) and ergine (LA-111), which are reasonable cases due to these compounds having other far-better-known names. Thank you. – AlyInWikiWonderland (talk, contribs) 23:57, 19 October 2025 (UTC)Reply

The discussion above is closed. Please do not modify it. Subsequent comments should be made on the appropriate discussion page. No further edits should be made to this discussion.